Using CRISPR Interference as a Therapeutic Approach to Treat TGFß2-Induced Ocular Hypertension and Glaucoma.
Invest Ophthalmol Vis Sci
; 62(12): 7, 2021 09 02.
Article
in En
| MEDLINE
| ID: mdl-34499703
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Trabecular Meshwork
/
Glaucoma, Open-Angle
/
Ocular Hypertension
/
Transforming Growth Factor beta2
/
Clustered Regularly Interspaced Short Palindromic Repeats
/
Intraocular Pressure
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Invest Ophthalmol Vis Sci
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: